시장보고서
상품코드
1629159

자동 비활성화 주사기 시장 : 제품 유형별, 증상별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Auto Disable Syringes Market, By Product Type, By Indication, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 288 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

세계의 자동 비활성화 주사기 시장 규모는 2023년에 235억 6,054만 달러로 평가되며, 2024-2032년에 CAGR 11.50%로 확대할 것으로 예측됩니다.

자동 비활성화 주사기 시장 : 시장 역학

바늘에 찔린 부상과 교차 감염 증가가 시장에 큰 영향을 미칠 것으로 예상됩니다.

자동 비활성화 주사기는 재사용을 방지하도록 설계되어 HIV, B형 간염, C형 간염과 같은 감염성 질환의 전염 위험을 줄일 수 있습니다. 의료진과 환자들 사이에서는 안전한 주사 요령의 중요성에 대한 인식이 높아지고 있습니다. 간호사의 바늘에 찔리거나 날카로운 부상의 유병률은 매우 높았으며(95.36%), 약 절반이 5회 이상 부상을 입었습니다. 미국 국립보건원에 따르면 여성 간호사와 응급실에 근무하는 간호사가 바늘에 찔리거나 날카로운 물체에 찔릴 가능성이 더 높았다(각각 p=0.018, 0.021). 또한 비용 효율적이고 환경 친화적인 재료를 포함한 주사기 제조의 혁신은 시장에 성장 기회를 가져올 수 있습니다. 그러나 환경 문제는 시장 성장을 제한할 수 있는 요인으로 작용할 수 있습니다.

자동 비활성화 주사기 시장 : 주요 인사이트

당사의 리서치 애널리스트들의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 약 11.50%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

용도별로는 백신 접종이 2023년 주요 부문으로 꼽혔습니다.

최종사용자별로는 병원이 2023년 주요 부문으로 꼽혔습니다.

지역별로는 북미가 2023년 주요 수입원이었습니다.

자동 비활성화 주사기 도시: 세분화 분석 :

세계의 자동 비활성화 주사기 시장은 제품 유형, 증상, 애플리케이션, 최종사용자, 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 개폐식, 비개폐식, 기타 두 가지 범주로 나뉩니다. 각 카테고리에는 안전성을 향상시키고 주사기 재사용 가능성을 제거하기 위해 고안된 서로 다른 기술이 포함되어 있습니다. 개폐식 무력화 주사기는 주사침 손상과 교차 오염의 위험을 크게 줄일 수 있으며, 병원, 진료소, 예방접종 기관에서 널리 사용되고 있습니다. 비개폐식 비활성화 주사기는 일반적으로 플런저를 잠그거나 배럴을 파손하여 한 번의 사용으로 주사기를 사용할 수 없도록 하는 메커니즘을 갖추고 있습니다.

시장은 증상별로 감염성 질환과 염증성 질환/자가면역질환의 두 가지로 나뉩니다. 이 분류는 백신 접종 및 만성질환 관리와 같은 주요 의료 우선순위와 시장의 일치성을 반영한다는 점에서 매우 중요합니다. 간염, HIV, 결핵, COVID-19와 같은 질병에 대한 백신 접종에 대한 관심이 높아지면서 안전 설계 주사기에 대한 수요가 크게 증가하고 있습니다. 선진국에서는 의료제도가 발달하여 시장 개척이 이루어지고 있는 반면, 신흥 국가 시장에서는 자가면역질환의 유행이 증가하고 있습니다. 두 분야 모두 주사제 안전에 대한 관심 증가, 의료비 지출 증가, 주사바늘 재사용과 관련된 위험을 줄여야 할 필요성에 의해 주도되고 있습니다.

시장은 용도에 따라 채혈, 약물전달, 백신 접종 등 세 가지 주요 카테고리로 나뉩니다. 백신 접종은 시장 성장의 주요 원동력이 되고 있습니다. 자동 비활성화 주사기는 재사용 가능성을 제거하도록 특별히 설계되어 백신 투여의 안전성을 높이고 교차 오염 및 감염 전파 가능성을 줄입니다. 이러한 특성으로 인해 백신은 감염병 대응을 위한 공중보건 전략에서 매우 중요한 요소로 작용하고 있습니다. 특히 세계보건기구(WHO)나 Gavi(백신동맹)와 같은 단체에서 시행하는 대규모 백신 접종 활동에서 자동무효화 주사기 도입은 매우 중요합니다.

최종사용자에 따라 시장은 병원, 클리닉, 진단 실험실, 외래수술센터(ASC) 및 기타 4개로 분류됩니다. 병원은 이 시장에서 주도적인 역할을 하고 있습니다. 치료 및 백신 접종의 주요 시설로 기능하는 병원은 바늘 재사용 및 오염과 관련된 위험을 최소화하기 위해 필수적인 자동 비활성화 주사기의 주요 소비자입니다. 의료 서비스의 주요 공급자인 병원은 다양한 의료 목적으로 자동 비활성화 주사기를 채택하는 데 도움을 주고 있습니다.

자동 비활성화 주사기 시장 : 지역적 인사이트

이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카 등 지역적으로 광범위하게 분포되어 있습니다. 이 지역은 사업 활동에 기여하는 국가에 따라 더 세분화됩니다. 북미가 시장을 주도하고 있는 것은 주로 의료 지출 증가에 기인합니다. 의료 시스템 강화를 위한 자원 배분 증가는 자동 비활성화 주사기와 같은 첨단 의료기기의 보급을 촉진하고 있습니다. 메디케어-메디케이드 서비스 센터에 따르면 미국의 의료비 지출은 2022년 4.1% 증가하여 총 4조 5,000억 달러, 국민 1인당 1만 3,493달러를 기록할 것으로 예상했습니다. 의료비는 국내 총생산의 17.3%를 차지합니다. 유럽은 예방접종 수요 증가로 인해 시장 성장률 2위 지역이 되었습니다.

자동 비활성화 주사기 시장 : 경쟁 구도:

자동 비활성화 주사기 시장은 안전한 주사 방법에 대한 세계 수요 증가, 규제 요건, 기술 혁신에 힘입어 치열한 경쟁이 치열하게 도입되고 있습니다. 기업은 안전성을 향상시키기 위해 개폐식 주사바늘, 변조 방지 설계 등 정교한 기능 개발에 주력하고 있습니다. 선진 지역에서는 유명한 세계 기업이 시장을 선도하며 고품질의 기술적으로 우수한 주사기를 제공합니다. 제조업체들은 또한 규모의 경제를 활용하여 제품 안전 기준을 유지하면서 생산 비용을 낮추기 위해 규모의 경제를 활용하고 있습니다.

목차

제1장 자동 비활성화 주사기 시장 개요

  • 조사 범위
  • 시장 추정연도

제2장 개요

  • 시장 내역
  • 경쟁 인사이트

제3장 자동 비활성화 주사기의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 향후 동향

제4장 자동 비활성화 주사기 업계 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 지도제작
  • 규제 구조 분석

제5장 자동 비활성화 주사기 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 자동 비활성화 주사기 시장 구도

  • 자동 비활성화 주사기 시장 점유율 분석 : 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업의 분석
    • 신규 기업의 분석

제7장 자동 비활성화 주사기 시장 : 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 리트랙터블
    • 비리트랙터블
    • 기타

제8장 자동 비활성화 주사기 시장 : 증상별

  • 개요
    • 증상별 부문 점유율 분석
    • 감염증
    • 염증성 질환/자가면역질환

제9장 자동 비활성화 주사기 시장 : 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 채혈
    • 약물전달
    • 예방 접종

제10장 자동 비활성화 주사기 시장 : 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원
    • 진료소
    • 진단 검사실
    • 외래 수술 센터
    • 기타

제11장 자동 비활성화 주사기 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 : 자동 비활성화 주사기 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 개요
    • AdvaCare Pharma
    • Al Shifa Medical Products Co.
    • Apple Syringe
    • Becton Dickinson &Company
    • Duopross Meditech Corp.
    • Hindustan Syringes &Medical Devices Ltd
    • Hunan Pingan Medical Device Technology Co., Ltd.
    • Injecto A/S
    • Iscon Surgicals Ltd.
    • JMI SYRINGES &MEDICAL DEVICES LTD.
    • Merck KGaA
    • PT Oneject Indonesia
    • Retractable Technologies, Inc.
    • Sanavita Pharmaceuticals GmbH
    • Shandong Zhushi Pharmaceutical Group Co.,Ltd.
    • Shanghai Kohope Medical Devices Co., Ltd.
    • Shenzhen Medis Medical
    • Terumo Corporation
    • Others

제13장 애널리스트의 전방위 전망

KSA 25.02.06

REPORT HIGHLIGHT

The Auto-Disable Syringes Market was valued at USD 23,560.54 million in 2023 and expanded at a CAGR of 11.50% from 2024 to 2032.

Auto-disable syringe mechanisms are engineered to eliminate the possibility of syringe reuse. These devices are predominantly utilized in immunization initiatives, especially in developing nations, to guarantee the secure disposal of syringes and mitigate the spread of bloodborne pathogens. Typically, auto-disable syringes incorporate a mechanism that engages after a single application. They are frequently employed in large-scale vaccination efforts, where rapid immunization of numerous individuals is essential. Following their use, the auto-disable function ensures that the syringes are rendered unusable, encouraging safe disposal methods.

Auto Disable Syringes Market- Market Dynamics

The increasing prevalence of needle stick injuries and cross infections is anticipated to influence the market significantly

Auto-disable syringes are designed to prevent reuse, thereby reducing the risk of transmission of infectious diseases such as HIV, hepatitis B, and hepatitis C, which are often spread through contaminated or reused needles. There is growing awareness among healthcare providers and patients about the importance of safe injection practices. The prevalence of needle sticks and sharp injuries among nurses was very high (95.36%), and around half were injured more than five times. Female nurses and those in an emergency department were more likely to be subjected to needle sticks and sharp injuries (p = 0.018 and 0.021, respectively), According to the National Institutes of Health. Furthermore, Innovations in syringe manufacturing, including cost-effective and eco-friendly materials may provide growth opportunities for the market. However, Environmental Concerns may restrict the market growth.

Auto Disable Syringes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.50% over the forecast period (2024-2032)

Based on Application segmentation, Vaccination was the leading segment in 2023

Based on End-User segmentation, Hospitals was the leading segment in 2023

Based on region, North America was the leading revenue generator in 2023

Auto Disable Syringes Market- Segmentation Analysis:

The Global Auto Disable Syringes Market is segmented based on Product Type, Indication, Application, End-User, and Region.

The market is divided into two specific categories based on product type: Retractable, Non-Retractable, and others. Each category encompasses different technologies designed to improve safety and eliminate the possibility of syringe reuse. Retractable Disable Syringes are favored for their ability to significantly lower the risk of needle stick injuries and cross-contamination, making them widely utilized in hospitals, clinics, and vaccination initiatives. Non-retractable disable Syringes feature a mechanism that renders the syringe unusable after a single use, typically by locking the plunger or breaking the barrel.

The market is divided into two segments based on Indication: Infectious Diseases and Inflammatory/Auto-Immune Diseases. This classification is crucial as it reflects the market's alignment with key medical priorities, including vaccination efforts and the management of chronic conditions. The heightened emphasis on vaccination initiatives for diseases such as hepatitis, HIV, tuberculosis, and COVID-19 significantly enhances the demand for safety-engineered syringes. Growth is observed in developed regions due to their advanced healthcare systems while emerging markets are experiencing an increase in auto-immune disease prevalence. Both segments are propelled by a growing focus on injection safety, rising healthcare expenditures, and the necessity to reduce risks linked to needle reuse.

The market is divided into three main categories based on application: Blood Collection, Drug Delivery, and Vaccination. Vaccination serves as the key catalyst for market growth. Auto-disable syringes are specifically designed to eliminate the possibility of reuse, thereby enhancing the safety of vaccine administration and decreasing the likelihood of cross-contamination and infection transmission. This characteristic makes them a crucial component in public health strategies aimed at combating infectious diseases. The implementation of auto-disable syringes is especially important in large-scale vaccination efforts conducted by entities such as the World Health Organization (WHO) and Gavi, the Vaccine Alliance.

The market is divided into four main categories based on the End-User: Hospitals, Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, and Others. Hospitals occupy a leading role in this market. Serving as the primary facilities for treatment and vaccination, hospitals are major consumers of auto-disable syringes, which are vital for minimizing the risks linked to needle reuse and contamination. As key providers of healthcare services, hospitals are instrumental in the adoption of auto-disable syringes for a range of medical purposes.

Auto Disable Syringes Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further segmented based on the countries contributing to business activities. North America leads the market, primarily due to an increase in healthcare expenditures. The growing allocation of resources towards enhancing healthcare systems has facilitated the widespread adoption of advanced medical devices, such as auto-disable syringes. According to the Centers for Medicare and Medicaid Services, healthcare spending in the United States rose by 4.1 percent in 2022, totaling USD 4.5 trillion, or USD 13,493 per capita. Health expenditures represented 17.3 percent of the nation's Gross Domestic Product. Europe ranks as the second-largest region for market growth, driven by a rising demand for immunization coverage.

Auto Disable Syringes Market- Competitive Landscape:

The market for auto-disable syringes is characterized by intense competition, fueled by rising global demand for secure injection methods, regulatory requirements, and innovations in technology. Firms are focusing on the development of sophisticated features, including retractable needles and tamper-resistant designs, to improve safety. Prominent global corporations lead the market in developed regions, offering high-quality and technologically superior syringes. Manufacturers are also capitalizing on economies of scale to lower production costs while upholding safety standards for their products.

Recent Developments:

On September 18, 2024, BD (Becton, Dickinson, and Company), a prominent global medical technology firm, declared the commercial launch of the BD Neopak XtraFlow Glass Prefillable Syringe. Additionally, the company announced an expansion in capacity for the BD Neopak Glass Prefillable Syringe platform to meet the increasing demand in the biologic therapies market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AUTO DISABLE SYRINGES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AdvaCare Pharma
  • Al Shifa Medical Products Co.
  • Apple Syringe
  • Becton Dickinson & Company
  • Duopross Meditech Corp.
  • Hindustan Syringes & Medical Devices Ltd
  • Hunan Pingan Medical Device Technology Co., Ltd.
  • Injecto A/S
  • Iscon Surgicals Ltd.
  • JMI SYRINGES & MEDICAL DEVICES LTD.
  • Merck KGaA
  • PT Oneject Indonesia
  • Retractable Technologies, Inc.
  • Sanavita Pharmaceuticals GmbH
  • Shandong Zhushi Pharmaceutical Group Co., Ltd.
  • Shanghai Kohope Medical Devices Co., Ltd.
  • Shenzhen Medis Medical
  • Terumo Corporation
  • Others

GLOBAL AUTO DISABLE SYRINGES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Retractable
  • Non-Retractable
  • Others

GLOBAL AUTO DISABLE SYRINGES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Diseases
  • Inflammatory/Auto-Immune Diseases

GLOBAL AUTO DISABLE SYRINGES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Blood Collection
  • Drug Delivery
  • Vaccination

GLOBAL AUTO DISABLE SYRINGES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers
  • Others

GLOBAL AUTO DISABLE SYRINGES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Auto Disable Syringes Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Auto Disable Syringes Market Snippet by Product Type
    • 2.1.2. Auto Disable Syringes Market Snippet by Indication
    • 2.1.3. Auto Disable Syringes Market Snippet by Application
    • 2.1.4. Auto Disable Syringes Market Snippet by End-User
    • 2.1.5. Auto Disable Syringes Market Snippet by Country
    • 2.1.6. Auto Disable Syringes Market Snippet by Region
  • 2.2. Competitive Insights

3. Auto Disable Syringes Key Market Trends

  • 3.1. Auto Disable Syringes Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Auto Disable Syringes Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Auto Disable Syringes Market Opportunities
  • 3.4. Auto Disable Syringes Market Future Trends

4. Auto Disable Syringes Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Auto Disable Syringes Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Auto Disable Syringes Market Landscape

  • 6.1. Auto Disable Syringes Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Auto Disable Syringes Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Retractable
    • 7.1.3. Non-Retractable
    • 7.1.4. Others

8. Auto Disable Syringes Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Infectious Diseases
    • 8.1.3. Inflammatory/Auto-Immune Diseases

9. Auto Disable Syringes Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Blood Collection
    • 9.1.3. Drug Delivery
    • 9.1.4. Vaccination

10. Auto Disable Syringes Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Diagnostic Laboratories
    • 10.1.5. Ambulatory Surgical Centers
    • 10.1.6. Others

11. Auto Disable Syringes Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Auto Disable Syringes Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Auto Disable Syringes Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Auto Disable Syringes Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Auto Disable Syringes Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Auto Disable Syringes Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Auto Disable Syringes Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. AdvaCare Pharma
    • 12.2.2. Al Shifa Medical Products Co.
    • 12.2.3. Apple Syringe
    • 12.2.4. Becton Dickinson & Company
    • 12.2.5. Duopross Meditech Corp.
    • 12.2.6. Hindustan Syringes & Medical Devices Ltd
    • 12.2.7. Hunan Pingan Medical Device Technology Co., Ltd.
    • 12.2.8. Injecto A/S
    • 12.2.9. Iscon Surgicals Ltd.
    • 12.2.10. JMI SYRINGES & MEDICAL DEVICES LTD.
    • 12.2.11. Merck KGaA
    • 12.2.12. PT Oneject Indonesia
    • 12.2.13. Retractable Technologies, Inc.
    • 12.2.14. Sanavita Pharmaceuticals GmbH
    • 12.2.15. Shandong Zhushi Pharmaceutical Group Co.,Ltd.
    • 12.2.16. Shanghai Kohope Medical Devices Co., Ltd.
    • 12.2.17. Shenzhen Medis Medical
    • 12.2.18. Terumo Corporation
    • 12.2.19. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제